Recombinant Human Osteoprotegerin is produced by our Mammalian expression system and the target gene encoding Glu22-Leu201 is expressed with a Fc tag at the C-terminus. Bon Opus Cat. #CK44

Recombinant Human TNF Receptor Superfamily Member 11B/OPG (C-Fc)

Name: Recombinant Human TNF Receptor Superfamily Member 11B/OPG (C-Fc)
SKU: CK44-10ug

SKU: CK44-10ug

$158.00

Quantity

[{"key":"CK44-1mg","value":"Backorder"},{"key":"CK44-50ug","value":"Backorder"},{"key":"CK44-10ug","value":"Backorder"},{"key":"CK44-500ug","value":"Backorder"}]

FAQ

Contact Us

Phone: 800-943-6396 ext#1

Email: orders@bonopusbio.com

Distributors

Have Other Questions?

Shipping Information

$48 Standard Overnight flat rate for products shipped in room temperature within the United States.

Additional $27 Ice Packs shipment fee is required for liquid proteins.

Please contact us to order for international shipments.

Certificate of Analysis

Datasheet not available? Submit a request here

Endotoxin

Less than 0.1 ng/ug (1 EU/ug) as determined by LAL test.

Accession Number

O00300

Species

Human

Expression System

Human Cells

Target Sequence

Glu22-Leu201

C-Fc

Formulation

Lyophilized from a 0.2 um filtered solution of PBS, pH 7.4.

Packaging

Ambient

Background

TNFRSF11B is a secreted protein, containing 2 death domains and 4 TNFR-Cys repeats. TNFRSF11B is a decoy receptor for the receptor activator of nuclear factor kappa B ligand (RANKL). By binding RANKL, TNFRSF11B inhibits nuclear kappa B (NF-κB) which is a central and rapid acting transcription factor for immune-related genes, and a key regulator of inflammation, innate immunity, and cell survival and differentiation. TNFRSF11B levels are influenced by voltage-dependent calcium channelsCav1.2. TNFRSF11B can reduce the production of osteoclasts by inhibiting the differentiation of osteoclast precursors into osteoclasts and also regulates the resorption of osteoclasts in vitroand in vivo. TNFRSF11B binding to RANKL on osteoblast/stromal cells, blocks the RANKL-RANK ligand interaction between osteoblast/stromal cells and osteoclast precursors. This has the effect of inhibiting the differentiation of the osteoclast precursor into a mature osteoclast.